The Safety, Tolerability, and Immunogenicity Profiles of a Single Dose of V114, PNEUMOVAX® 23, or PREVNAR 13® in Adults 50 Years of Age or Older (V114-002)
Condition(s):Pneumococcal InfectionsLast Updated:December 13, 2018Completed
Hide Studies Not Open or Pending
Condition(s):Pneumococcal InfectionsLast Updated:December 13, 2018Completed
Condition(s):Vaccines, Pneumococcal Conjugate VaccineLast Updated:December 20, 2018Completed
Condition(s):Pneumococcal DiseaseLast Updated:December 3, 2018Completed
Condition(s):Pneumococcal InfectionLast Updated:October 5, 2016Completed
Condition(s):Recurrent Acute Otitis MediaLast Updated:December 20, 2010Completed
Condition(s):VaccinationLast Updated:February 2, 2021Completed
Condition(s):Healthy ParticipantsLast Updated:February 7, 2024Recruiting
Condition(s):PneumoniaLast Updated:June 24, 2022Not yet recruiting
Condition(s):Acute Otitis MediaLast Updated:June 20, 2018Completed
Condition(s):Pneumococcal InfectionsLast Updated:October 21, 2008Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.